Cytokine Storm Syndrome Responsive to IL-1 Inhibition in Trisomy 21

Area of Science:

• Immunology
• Genetics
• Pediatrics

Background:

• Cytokine storm syndromes (CSS) are severe inflammatory conditions resulting from immune dysregulation.
• Trisomy 21 (TS21), or Down syndrome, is associated with immune dysfunction and inflammation.
• The role of TS21 as a primary cause of CSS, independent of infection, remains unclear.

Observation:

• A 16-year-old male with TS21 presented with symptoms of CSS, including fever, rash, joint pain, and abdominal issues.
• Infections, autoimmune diseases, malignancy, and primary immune deficiencies were excluded as triggers.
• The patient's condition improved with IL-1 inhibition and corticosteroid therapy.

Findings:

• This case suggests TS21 itself may predispose individuals to CSS.
• The positive response to IL-1 inhibition points to IL-1 superfamily and NLRP3 inflammasome dysregulation in TS21-associated CSS.
• Trisomy 21 is an immune dysregulation disorder.

Implications:

• Clinicians should consider CSS in TS21 patients, even with unidentified triggers.
• IL-1 inhibition may be a viable therapeutic strategy for CSS in the TS21 population.
• Further research into the mechanisms of CSS in TS21 is warranted.